| Literature DB >> 25192820 |
Gaurav Bharadwaj1, Patricia G Z Benini1, Debashree Basudhar1, Cyf N Ramos-Colon1, Gail M Johnson1, Marti M Larriva1, Larry K Keefer2, Daniela Andrei2, Katrina M Miranda3.
Abstract
Nitroxyl (HNO) donors have been shown to elicit a variety of pharmacological responses, ranging from tumoricidal effects to treatment of heart failure. Isopropylamine-based diazeniumdiolates have been shown to produce HNO on decomposition under physiological conditions. Herein, we report the synthesis and HNO release profiles of primary alicyclic amine-based diazeniumdiolates. These compounds extend the range of known diazeniumdiolate-based HNO donors. Acetoxymethyl ester-protected diazeniumdiolates were also synthesized to improve purification and cellular uptake. The acetoxymethyl derivative of cyclopentylamine diazeniumdiolate not only showed higher cytotoxicity toward cancer cells as compared to the parent anion but was also effective in combination with tamoxifen for targeting estrogen receptor α-negative breast cancer cells.Entities:
Keywords: Angeli's salt; Diazeniumdiolate; IPA/NO; Nitric oxide; Nitroxyl; Tamoxifen
Mesh:
Substances:
Year: 2014 PMID: 25192820 PMCID: PMC4258449 DOI: 10.1016/j.niox.2014.08.013
Source DB: PubMed Journal: Nitric Oxide ISSN: 1089-8603 Impact factor: 4.427